Business Wire Feed
Navitus Achieves HITRUST r2 Certification, Reinforcing Its Commitment to Cybersecurity and Information Protection
HITRUST Certification confirms Navitus continues to meet rigorous, independently validated standards for cybersecurity and data protectionMADISON, Wis.--(BUSINESS WIRE)--Navitus, the nation’s first and largest transparent, pass-through pharmacy benefit manager (PBM), today announced it has earned HITRUST more...
Serenity Mental Health Centers Expands Mental Health Services in Las Vegas
Clinic provides innovative mental health services in Las Vegas to help residents healLAS VEGAS--(BUSINESS WIRE)--Serenity Mental Health Centers, a leader in psychiatric care and one of the fastest growing mental health providers in the nation, more...
QIAGEN N.V. to Release Results for Q4 2025 and Hold Webcast
VENLO, Netherlands--(BUSINESS WIRE)--QIAGEN N.V. (NYSE: QGEN) (Frankfurt Stock Exchange: QIA) today announced plans to release results for the fourth quarter of 2025. Press release date / time: Wednesday, February 4 shortly after 22:05 Frankfurt time more...
Naturmega® Announces Peer-Reviewed Clinical Results for Ruby-O® Balance, Demonstrating Stronger Triglyceride Responder Outcomes with a Lower Omega-3 Dose
Published in BMC Complementary Medicine and Therapies, the study validates Ruby-O®’s bonded phospholipid omega-3 platform as a more efficient, cell-oriented approach to omega-3 delivery.BARRANQUILLA, Colombia--(BUSINESS WIRE)--#CardiometabolicHealth--Naturmega, a pioneer in advanced lipid science, announced the results more...
Guardant Health Announces Multi-Year Strategic Collaboration Agreement with Merck to Develop Companion Diagnostics and Commercialize New Cancer Therapies Using Guardant Infinity Smart Platform
Multi-year global collaboration will utilize Guardant liquid biopsy portfolio for the development of companion diagnostics for drug approvalsPALO ALTO, Calif.--(BUSINESS WIRE)--$GH--Guardant Health, Inc. (Nasdaq: GH), a leading precision oncology company, today announced a multi-year collaboration more...
Alta Semper Signs Definitive Agreements to Acquire a Majority Stake in Nature’s Rule, a MENA-Focused Leader in Dietary Supplements and Sports Nutrition
LONDON & CAIRO--(BUSINESS WIRE)--Alta Semper, a London-based private equity firm focused on healthcare and consumer investments across growth markets, today announced that it has signed definitive agreements to acquire a majority stake in Nature’s Rule, more...
ENHERTU® Plus Pertuzumab Type II Variation Application Validated in the EU as First-Line Treatment of Patients with HER2 Positive Metastatic Breast Cancer
Based on DESTINY-Breast09 phase 3 trial results that showed Daiichi Sankyo and AstraZeneca’s ENHERTU in combination with pertuzumab significantly improved progression-free survival versus current first-line standard of care in HER2 positive metastatic breast cancer TOKYO more...
Median Technologies Reports Landmark 2025 Performance With Major Regulatory and Commercial Milestones Ahead in 2026
Record iCRO bookings in 2025; order backlog at an all-time high of €76.6 million despite negative forex impact of € (6.5) million 2025 revenue of €23.5 million, up 2.6% vs 2024 despite negative forex impact more...
Organon Announces US Food and Drug Administration Approval of Supplemental New Drug Application Extending Duration of Use of NEXPLANON® (etonogestrel implant) 68 mg Radiopaque
JERSEY CITY, N.J.--(BUSINESS WIRE)--Organon (NYSE: OGN), a global healthcare company with a mission to deliver impactful medicines and solutions for a healthier every day, announced today that the US Food and Drug Administration (FDA) has more...
Bloom: Celebrating AHF’s Activism Through Augmented Reality and Art
2 Night Only Art Exhibition in Hollywood, January 20 and 21, 6:00 p.m. – 9:00 p.m.LOS ANGELES--(BUSINESS WIRE)--“Bloom,” a multi-sensory art experience that converts two physical murals into living, breathing works of art, will land more...
Repare Shareholders Approve Acquisition by XenoTherapeutics, Inc.
CAMBRIDGE, Mass. & MONTREAL--(BUSINESS WIRE)--Repare Therapeutics Inc. (“Repare” or the “Company”) (Nasdaq: RPTX), a clinical-stage precision oncology company, today announced that its Shareholders (as defined below) have approved the acquisition of all of the issued more...
Spark® Green Apple Candy Makes Its New Year Debut
This Limited‑Time Flavor Brings Sweet Candy Energy to the New YearRICHARDSON, Texas--(BUSINESS WIRE)--#AdvoCareRehydrate--Ring in the new year with Spark® Green Apple Candy, available for a limited time and bringing crave‑worthy sweet candy flavor to fuel more...
Genmab Announces Topline Results for Epcoritamab (DuoBody® CD3xCD20) from Phase 3 EPCORE® DLBCL-1 Trial in Patients with Relapsed/Refractory Diffuse Large B-cell Lymphoma (DLBCL)
Company Announcement Based on the topline results from the EPCORE® DLBCL-1 trial, Genmab will engage global regulatory authorities to discuss next steps COPENHAGEN, Denmark--(BUSINESS WIRE)--Genmab A/S (Nasdaq: GMAB) today announced topline results from the Phase more...
Prime Healthcare Expands Mission in Illinois with Franciscan Health Olympia Fields
Olympia Fields will become the ninth hospital in Illinois, reflecting Prime’s commitment to continuing a legacy of service, preserving access and advancing clinical excellenceONTARIO, Calif. & OLYMPIA FIELDS, Ill.--(BUSINESS WIRE)--#AccessToCare--Prime Healthcare today announced it has more...
Legislation Eliminates Financial Barriers to Critical Breast Imaging, Would Help Thousands Across Arizona Afford Care They Require
Susan G. Komen® Applauds Bill Introduction, Urges Quick PassagePHOENIX--(BUSINESS WIRE)--Susan G. Komen®, the world’s leading breast cancer organization commends Senator Hildy Angius (R-Bullhead City) for introducing legislation to ensure equitable access to required diagnostic and more...
VASA Fitness Opens Eighteenth Club in Colorado, Expanding Access to High-Value Fitness in the State
Full-Amenity, Affordable Fitness Leader Continues Colorado Growth With Third Aurora LocationAURORA, Colo.--(BUSINESS WIRE)--VASA Fitness, one of the nation’s largest high-value, low-price fitness operators, is opening its newest location in Aurora at 1200 South Ironton Street. more...
Colgate-Palmolive Webcasts 2025 Fourth Quarter & Full Year Earnings Conference Call January 30, 2026 – 8:30 a.m. ET
NEW YORK--(BUSINESS WIRE)--Colgate-Palmolive Company (NYSE:CL) will provide a live webcast of its 2025 fourth quarter and full year earnings conference call on Friday, January 30, 2026, at 8:30 a.m. ET. The call will be hosted more...
Innovaccer and Hospitalogy Release ‘Autonomous Healthcare’ Report, Revealing Key Margin and Operating Trends Across Major Health Systems
Report examines 2025 financial performance and operating efficiency across the nation’s most influential health systems amid growing administrative and operational complexitySAN FRANCISCO--(BUSINESS WIRE)--Innovaccer Inc., a leading healthcare AI company, and Hospitalogy, a healthcare research and more...
People Magazine Spotlights Tiffany Howard’s Metabolic Health Journey with OPTAVIA®
A Powerful Story of Improving Metabolic Health Through Science, Coaching and CommunityBALTIMORE--(BUSINESS WIRE)--Medifast® (NYSE: MED), the health and wellness company known for its science-backed, coach-guided lifestyle system OPTAVIA, celebrates the inspiring health transformation of Tiffany more...
ImmunityBio Announces Durable Complete Response of 15 Months with a Chemotherapy-Free CD19 CAR-NK Cell Therapy in Waldenstrom Lymphoma
Durable complete responses with CAR-NK + Rituximab in patients who failed current standards of care in Waldenstrom’s Non-Hodgkins lymphoma (NHL). Long-term evaluable patients demonstrate ongoing complete response of 7 and 15 months after receiving a more...
ImmunityBio Advances First-Line BCG Naive NMIBC Program with Enrollment Exceeding Expectations and Positive Interim Analysis for ANKTIVA® Plus BCG
Enrollment of BCG naïve subjects (QUILT-2.005) receiving BCG alone versus BCG plus ANKTIVA exceeding expectations 85% enrolled with anticipated completion in Q2 2026 with BLA filing to U.S. Food and Drug Administration (FDA) by year more...
Sila Realty Trust Completes $43.1 Million Acquisition of Oklahoma City Inpatient Rehabilitation Facility
TAMPA, Fla.--(BUSINESS WIRE)--Sila Realty Trust, Inc. (NYSE: SILA) (the “Company”, “we”, or “our”), a net lease real estate investment trust (“REIT”) with a strategic focus on investing in the growing and resilient healthcare sector, today more...
OrsoBio Announces Nature Medicine Publication Establishing Clinical and Mechanistic Validation of First-in-Class LXR Inverse Agonist TLC-2716 for the Treatment of Serious Metabolic Diseases
Findings confirm translation from human genetics, organoid systems, and preclinical models to Phase 1 clinical findingsMENLO PARK, Calif.--(BUSINESS WIRE)--#NatureMedicine--OrsoBio, Inc. (“OrsoBio” or “the Company”), a clinical-stage biopharmaceutical company developing treatments for obesity and related metabolic more...
Hologic to Announce Financial Results for the First Quarter of Fiscal 2026 on Thursday, January 29, 2026
MARLBOROUGH, Mass.--(BUSINESS WIRE)--$HOLX #earnings--Hologic, Inc. (Nasdaq: HOLX) announced today that the Company plans to release its financial results for the first quarter of fiscal 2026 on Thursday, January 29, after the market closes. As previously more...
AHF to ‘Stand Against Hate’ at Martin Luther King, Jr. Day Events Nationwide
AHF brings its potent civil rights and health care advocacy messaging via 22 events in 15 cities across ten states, including floats in major MLK, Jr. Day parades in Los Angeles and Dallas Group reasserts more...